跳至主要内容
临床试验/JPRN-UMIN000013147
JPRN-UMIN000013147招募中未知

Bixalomer versus calcium carbonate on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a randomized study. - BICOLOR STUDY

CKD-MBD Clinical Study Group0 个研究点目标入组 300 人开始时间: 2014年2月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Serum phosphate level 8.0mg/dL or more 2.Bowel obstruction 3. Severe chronic constipation or diarrhea 4. A history of gastrointestinal ulcer or bowel resection 5. Hypothyroidism 6. Severe cardiac disease (NYHA classification III-IV or wide range of old myocardial infarction) 7. A history of hospitalization for cerebrovascular or cardiovascular disease within a month 8. Liver dysfunction (AST or ALT more than 2-times the upper limit of institution, or T-Bil more than 1.5-times the upper limit ofinstitution) or severe liver disorders (active chronic hepatitis) 9. Pregnant, women on lactation or possibly pregnant women, or plan to get pregnant during the study 10. Having a disadvantage for CT scan (pacemaker, artificial valve, coronary artery stent, atrial fibrillation, etc.) 11. Ineligible patients according to the investigator's judgment

研究者

发起方
CKD-MBD Clinical Study Group

相似试验